The Europe Peripheral Intravenous Catheters market size was around USD 1.18 billion in 2018. It is expected to grow at a CAGR of 5.6% to reach USD 1.55 billion by 2023. It captures 27% of the global market.
Medication is administered straight into the circulation by placing a small tube peripheral vein and this is known as a peripheral intravenous (IV) catheter. Apart from administering medication, peripheral intravenous (IV) catheters are utilized for withdrawing blood from veins for testing. Advanced peripheral intravenous (IV) catheters are enabled with extra safety features in order to avoid needle stick injuries.
Augmenting geriatric population and advancement in surgical and treatment technologies resulting in rising surgical procedures are the primary drivers of market growth.
However, painful insertion, high cost of closed catheters, and need of trained medical professional to use peripheral intravenous (IV) catheters are primary restraints of market growth.
The market is segmented by type, end user and product. By type the market is segmented into Integrated/Closed catheters and Peripheral insertion catheters. By end user the market is segmented into Clinics, Ambulatory Surgery Centres (ASCs), Hospitals, and others. By product the market is segmented into Short PIVC and Integrated/Closed PIVC. By product, the short peripheral intravenous catheter category captured 73% of market share. By end users, hospitals category generated the highest revenue capturing approximately 61.4% share in 2014. Ambulatory surgical centres category was the second-largest category by end users, capturing 19.6% revenue share.
By geography the market is segmented into UK, Spain, Germany, France and others. Europe is the second largest market. Augmenting geriatric population, high healthcare spending and advancement in technology resulting in higher rates of surgical procedures, and highly developed healthcare infrastructure are the reasons attributable to the observable trend mentioned above.
Key players in the market include Smith Medical, Terumo Corporation, C. R. Bard, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Tangent Medical, and Vygon Group.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Introduction
5.1.2 Short PIVC
5.1.2.1 Ported Peripheral Intravenous Catheter
5.1.2.2 Non-ported Peripheral Intravenous Catheter
5.1.3 Integrated/Closed PIVC
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 Type
5.2.1 Introduction
5.2.2 Integrated/Closed catheters
5.2.3 Peripheral insertion catheters
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Clinics
5.3.4 Ambulatory Surgery Centers (ASCs)
5.3.5 Home Use
5.3.6 Others
5.3.7 Y-o-Y Growth Analysis, By End User
5.3.8 Market Attractiveness Analysis, By End User
5.3.9 Market Share Analysis, By End User
5.4 Technology
5.4.1 Conventional Peripheral Intravenous Catheter
5.4.2 Safety Peripheral Intravenous Catheter
5.3.3 Y-o-Y Growth Analysis, By Technology
5.3.4 Market Attractiveness Analysis, By Technology
5.3.5 Market Share Analysis, By Technology
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Type
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Type
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Type
6.1.5.4 By End User
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Terumo Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 B. Braun Melsungen AG
8.3 Smiths Medical
8.4 Becton
8.5 Dickenson and Co.
8.6 Teleflex Inc.
8.7 C.R. Bard Inc.
8.8 Tangent Medical Technologies
8.9 Vygon SA
8.10 Argon Medical Devices Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
